Related Experiment Video
Updated: Jun 6, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Summary
Germ-cell tumors (GCTs) are highly curable cancers. This review covers new insights into GCT biology, prognosis, and treatment, focusing on international advancements and Italian contributions to improve cure rates.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Immunology
Context:
- Germ-cell tumors (GCTs) represent a unique model for cancer cure due to their high chemosensitivity, even in metastatic stages.
- Despite high cure rates, a subset of patients with GCTs do not achieve durable complete responses, necessitating further research and improved therapeutic strategies.
Purpose:
- To provide a comprehensive overview of recent advancements in the management of GCTs.
- To highlight novel findings in GCT biology, prognostic factors, and treatment modalities.
- To examine the specific contributions of the Italian GCT research community to international progress.
Summary:
- This paper synthesizes current knowledge on GCTs, covering their underlying biology, prognostic indicators, and therapeutic approaches.
- It emphasizes the significant progress made in understanding and treating these neoplasms, drawing from global research efforts.
- Special attention is given to the role of Italian research in advancing GCT management.
Impact:
- This review aims to inform oncologists and researchers about the latest developments in GCT care.
- It seeks to foster further research and clinical trials to enhance cure rates for all GCT patients.
- The findings underscore the importance of international collaboration and national contributions in optimizing cancer treatment outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...